Bicara Therapeutics’ $315 Million IPO

Leila Ahmed North America Legal Chronicle
Tagged:

Goodwin Procter advised Bicara Therapeutics on the offering, and Ropes & Gray advised the underwriters.Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company, announced the pricing…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here